Cellectricon would like to thank for all the rewarding scientific interactions at the recent Neuroscience 2018 meeting. Especially, we appreciate all the positive feedback and interest in our novel in vitro assay platform for neurodegenerative disease research. If you did not attend the meeting, or missed the poster presentations, you can contact us to learn more about the assays presented and to receive a copy of the posters.
- A high-throughput assay to assess the morphological and electrophysiological impact of neurodegenerative disease associated peptides on cortical neurons
Date: Nov 4, 2018
Presentation Time: 10:00 am – 11:00 am
Presentation Number: 133.07
Poster Board Number: T1
- In vitro modelling of prion-like mechanisms occurring in neurodegenerative diseases using a novel high throughput assay platform
Date: Nov 4, 2018
Presentation Time: 10:00 am – 11:00 am
Presentation Number: 133.15
Poster Board Number: T9
- Disease modelling of bipolar disorder and drug evaluation in patient-derived induced pluripotent stem cell cortical circuits
Date: Nov 5, 2018
Presentation Time: 8:00 am – 9:00 am
Presentation Number: 278.13
Poster Board Number: B8
- Examination of the role of Nav1.7 and Nav1.8 in the generation of action potentials both in-vivo and in-vitro
Date: Nov 5, 2018
Presentation Time: 11:00 am – 12:00 pm
Presentation Number: 299.04
Poster Board Number: W17
- An in vitro approach to investigate excitability differences in DRG neurons from neuropathic and inflammatory pain disease models
Date: Nov 6, 2018
Presentation Time: 1:00 pm – 2:00 pm
Presentation Number: 572.05
Poster Board Number: W12
Jennie Svensson Dalén
Director, Marketing and Sales
Neuroscience 2018
If you did not attend the meeting, or missed the poster presentations, you can contact us to learn more about the assays presented and to receive a copy of the posters.